Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase EARLY_PHASE1 2Phase 2 2Phase 1/2 2Phase 1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1Breast 1

Conditions

Triple Negative Breast Neoplasms 1Prostatic Neoplasms 1Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 13pembrolizumab 9Biopsy 9Nivolumab 8Radiotherapy 7Specimen Handling 5Cyclophosphamide 5Temozolomide 4Radiosurgery 4fludarabine 3X-Rays 3Surgical Procedures, Operative 3Rituximab 3Paclitaxel 3Leukapheresis 3Ipilimumab 3Fluorodeoxyglucose F18 3Dexamethasone 3Bevacizumab 3Aspirin 3perflutren 2alovudine 2Vaccines 2Tirzepatide 2Positron-Emission Tomography 2Phantoms, Imaging 2Omeprazole 2Niacinamide 2Neoadjuvant Therapy 2Metastasectomy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Positron-Emission Tomography × 90 days × Clear all
NCT05477823 2026-06-02

Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer

University of Wisconsin, Madison

Phase EARLY_PHASE1 Active not recruiting
30 enrolled
Genitourinary

Prostatic Neoplasms

NCT06586047 2026-03-27

Breast Cancer PSMA PET

University of Iowa

Phase EARLY_PHASE1 Recruiting
30 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡